1-5 of 5
Brian Van Ness, PhD
Close
Sort by
Journal Articles

Generation of a Predictive Score for Ixazomib Response in Multiple Myeloma

Amit Kumar Mitra, PhD, Sanjoy Dey, Andrew Hangsleben, Michael Steinbach, Vipin Kumar, PhD, Brian Van Ness, PhD
Journal: Blood
Blood (2014) 124 (21): 5695.
https://doi.org/10.1182/blood.V124.21.5695.5695
Published: 2014
Journal Articles

Modeling Myeloma Treatment through Epigenetic Modification: Synergistic Combination of EZH2 and Histone Deacetylase Inhibitors

Taylor S Harding, B.A., Jessica Swanson, Brian Van Ness, PhD
Journal: Blood
Blood (2014) 124 (21): 5719.
https://doi.org/10.1182/blood.V124.21.5719.5719
Published: 2014
Journal Articles

Single-Cell Transcriptomics Identifies Intra-Tumor Heterogeneity in Human Myeloma Cell Lines

Amit Kumar Mitra, PhD, Holly Stessman, PhD, Michael A. Linden, MDPhD, Brian Van Ness, PhD
Journal: Blood
Blood (2014) 124 (21): 3385.
https://doi.org/10.1182/blood.V124.21.3385.3385
Published: 2014
Journal Articles

Comparative Analysis of in Vitro Chemosensitivity to Four Proteasome Inhibitors in Human Myeloma Cell Lines

Amit Kumar Mitra, PhD, Taylor S Harding, B.A., Brian Van Ness, PhD
Journal: Blood
Blood (2014) 124 (21): 3436.
https://doi.org/10.1182/blood.V124.21.3436.3436
Published: 2014
Journal Articles

Genetic Polymorphisms Identify the Likelihood of Bone Disease in Myeloma: Correlations with Myeloma Cell DKK1 Expression and High Risk Gene Signatures.

Brian G.M. Durie, MD, Brian Van Ness, PhD, Christine Ramos, PhD, Owen Stephens, Majda Haznadar, Antje Hoering, PhD, Jeff Haessler, PhD, Michael S. Katz, BS, Gregory R. Mundy, MD, Robert A. Kyle, MD, Gareth J. Morgan, MD, PhD, John Crowley, PhD, Bart Barlogie, MD, John Shaughnessy, Jr., PhD
Journal: Blood
Blood (2007) 110 (11): 816.
https://doi.org/10.1182/blood.V110.11.816.816
Published: 2007